As the new year gets going, most people have already set some New Year's resolutions (here's some if you're of the science-y academic ilk) and chief among these is usually to exercise more and lose that holiday weight after the mounds of cookies and pie. It is perhaps not a coincidence that the latest Science Magazine Breakthrough of the Year recognizes GLP-1 drugs, which have been shown not only to be effective in managing diabetes, but also has significant impact on weight loss. The demand for these drugs has skyrocketed over the last few years as the word of their efficacy has spread, leading to supply chain issues that could adversely affect diabetes patients dependent on the medications. As the various GLP-1 drugs remain in short supply, it seems a good time to explore these drugs, their potential contributions to global human health, and what can be done to ensure they are accessible to those who need them most.

As a scientist (or at least, a guy who likes science and works for a bioscience-oriented company), I am invested in the power of scientific research in improving the quality of human life across all arenas. It is particularly gratifying when our customers, who are all primarily research scientists, derive direct benefit from ABclonal's products in their published research. In this case, our business development director had a customer recently defend her thesis based on a publication that used several ABclonal catalog antibodies. I enjoyed reading her group's article that may lead to more effective treatment strategies for diabetes patients going forward, so let's get to it.

When I taught high school biology, a favorite part of the curriculum was cellular structures and functions. I set up an activity suggested by other experienced biology teachers that was based on the “Cell City,” a learning analogy where students would create an artwork of a city with the mitochondrion as a power plant and a vacuole as a lake. (Figure 1) I wish I saved their very creative projects, but I distinctly remember one group used the Chicago Transit Authority’s elevated train system map to represent the endoplasmic reticulum (ER), a very clever use of the analogy and a nod to city pride. It was also the first time these students really thought about vesicular transport, although they didn't fully understand its importance.

In March 2022, the United States Senate approved the Sunshine Protection Act, which would make Daylight Savings Time (DST) permanent starting in November of 2023. There was still some healthy debate over whether Americans should accept Standard Time versus DST as their new permanent or keep the current system of “spring forward, fall back.” Regardless of whether we will have DST forever, there is broad consensus that the clock switch every March and November is disruptive to our sleep patterns and our circadian rhythms.

Whether to save energy, increase night-time Trick-or-Treat hours on Halloween, get those few extra minutes of sun to squeeze in the last innings of a Little League or high school baseball game, or just to normalize our sleep patterns, even a seemingly obscure issue like switching between standard time and DST is tied to our health and well-being in our society. And this is why we have to consider how sleep and the circadian rhythm can affect our physiology.